Latest Breaking News On - Department of investigational cancer therapeutics - Page 1 : comparemela.com

New Cancer Missile Drugs May Be More Effective Than Traditional Chemotherapy

New Cancer Missile Drugs May Be More Effective Than Traditional Chemotherapy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Nick blackmerBrad mcgregorKathleen mooreDrug administrationVerywell healthStephenson cancer centerUniversity of oklahomaUniversity of texasMd anderson cancer centerDana farber cancer instituteLank centerDepartment of investigational cancer therapeuticsInvestigational cancer therapeuticsCancer centerGenitourinary oncologySide effects

Horizon CME Announces First Annual Summit for Oncology & Precision Medicine in Cancer

#industry #news #UK #2024 #insights #zenopa #recruitment #Horizon #CME #Annual #Therapeutics #Oncology #Medicine #Cancer

United statesComunidad autonoma de catalunaSan franciscoElmer bernstamKevanm shokatOwen garrickPatriciam lorussoHanim babikerToshio shimizuLas vegasElena garraldaBrian leeNellieb connallyStacie lindseyEarly drug development at vallMd anderson cancer center

PC14586 Targets Previously Undruggable p53 in Treatment of Solid Tumors

Despite previous unsuccessful attempts to target p53, investigators have continued to try to develop novel therapeutics directed at the tumor suppressor gene with the goal of restoring p53 wild-type activity.

United statesEcaterinae dumbravaNational cancer instituteEuropean organisation for researchUniversity of texas md anderson cancer centerAmerican association for cancer researchTreatment of cancer international conference on molecularDuring the american association for cancer researchDepartment of investigational cancer therapeuticsInvestigational cancer therapeuticsCancer centerDisplay efficacyAmerican associationCancer researchEuropean organisationCancer international conference

Dumbrava Details Ongoing Research With PC14586 in p53 Y220C–Mutated Advanced Solid Tumors

Dr Dumbrava discusses the rationale and design of the PYNNACLE trial; phase 1 efficacy and safety findings with PC14586 in patients with p53 Y220C–mutated advanced solid tumors; and the next steps for this research.

United statesEcaterinae dumbravaAshling wahnerDepartment of investigational cancer therapeuticsInternational conference on molecularDivision of cancer medicineUniversity of texas md anderson cancer centerLive on airInvestigational cancer therapeuticsCancer medicineCancer centerMolecular targetsCancer therapeuticsOnclive on airApple podcastsGoogle podcasts

Scholar Rock (SRRK) Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients

Scholar Rock (SRRK) Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoJay backstromSusan henryTimothy yapTranslational sciencesScholar rock incDepartment of investigational cancer therapeuticsSociety for immunotherapy of cancerUniversity of texas md anderson cancer centerScholar rockAnnual meetingChief executive officerEstablishing proofPreliminary biomarker data